-
Review
October 2, 2024
- Roles of X-box binding protein 1 in liver pathogenesis
- Jihoon Tak, Yun Seok Kim, Sang Geon Kim
- Clin Mol Hepatol. 2025;31(1):1-31.
- Review
- Roles of X-box binding protein 1 in liver pathogenesis
- Jihoon Tak, Yun Seok Kim, Sang Geon Kim
- Clin Mol Hepatol. 2025;31(1):1-31. Published online October 2, 2024
-
View: 1253 Download: 131
- Sinusoidal communication in chronic liver disease
- Albert Gibert-Ramos, María Andrés-Rozas, Raül Pastó, Pablo Alfaro-Retamero, Sergi Guixé-Muntet, Jordi Gracia-Sancho
- Clin Mol Hepatol. 2025;31(1):32-55. Published online October 2, 2024
-
View: 1001 Download: 183
- Bioactive metabolites: A clue to the link between MASLD and CKD?
- Wen-Ying Chen, Jia-Hui Zhang, Li-Li Chen, Christopher D. Byrne, Giovanni Targher, Liang Luo, Yan Ni, Ming-Hua Zheng, Dan-Qin Sun
- Clin Mol Hepatol. 2025;31(1):56-73. Published online October 21, 2024
-
View: 1125 Download: 145
- Long-term outcomes and risk modifiers of metabolic dysfunction-associated steatotic liver disease between lean and non-lean populations
- Pojsakorn Danpanichkul, Kanokphong Suparan, Vitchapong Prasitsumrit, Aijaz Ahmed, Karn Wijarnpreecha, Donghee Kim
- Clin Mol Hepatol. 2025;31(1):74-89. Published online October 23, 2024
-
View: 1808 Download: 291 Crossref: 6
- Hard-to-treat autoimmune hepatitis and primary biliary cholangitis: The dawn of a new era of pharmacological treatment
- Atsumasa Komori, Yuki Kugiyama
- Clin Mol Hepatol. 2025;31(1):90-104. Published online November 11, 2024
-
View: 779 Download: 154
- Original Article
- Carvedilol to prevent hepatic decompensation of cirrhosis in patients with clinically significant portal hypertension stratified by new non-invasive model (CHESS2306)
- Chuan Liu, Hong You, Qing-Lei Zeng, Yu Jun Wong, Bingqiong Wang, Ivica Grgurevic, Chenghai Liu, Hyung Joon Yim, Wei Gou, Bingtian Dong, Shenghong Ju, Yanan Guo, Qian Yu, Masashi Hirooka, Hirayuki Enomoto, Amr Shaaban Hanafy, Zhujun Cao, Xiemin Dong, Jing LV, Tae Hyung Kim, Yohei Koizumi, Yoichi Hiasa, Takashi Nishimura, Hiroko Iijima, Chuanjun Xu, Erhei Dai, Xiaoling Lan, Changxiang Lai, Shirong Liu, Fang Wang, Ying Guo, Jiaojian Lv, Liting Zhang, Yuqing Wang, Qing Xie, Chuxiao Shao, Zhensheng Liu, Federico Ravaioli, Antonio Colecchia, Jie Li, Gao-Jun Teng, Xiaolong Qi
- Clin Mol Hepatol. 2025;31(1):105-118. Published online July 11, 2024
-
View: 1926 Download: 243 Crossref: 1
- Safety and efficacy of HK-660S in patients with primary sclerosing cholangitis: A randomized double-blind phase 2a trial
- Woo Hyun Paik, Joo Kyung Park, Moon Jae Chung, Gunn Huh, Ce Hwan Park, Sang Hyub Lee, Heon Se Jeong, Hee Jin Kim, Do Hyun Park
- Clin Mol Hepatol. 2025;31(1):119-130. Published online September 24, 2024
-
View: 899 Download: 177
- Optimal tacrolimus levels for reducing CKD risk and the impact of intrapatient variability on CKD and ESRD development following liver transplantation
- Soon Kyu Lee, Ho Joong Choi, Young Kyoung You, Pil Soo Sung, Seung Kew Yoon, Jeong Won Jang, Jong Young Choi
- Clin Mol Hepatol. 2025;31(1):131-146. Published online October 2, 2024
-
View: 881 Download: 145
- USP29 alleviates the progression of MASLD by stabilizing ACSL5 through K48 deubiquitination
- Sha Hu, Zhouxiang Wang, Kun Zhu, Hongjie Shi, Fang Qin, Tuo Zhang, Song tian, Yanxiao Ji, Jianqing Zhang, Juanjuan Qin, Zhigang She, Xiaojing Zhang, Peng Zhang, Hongliang Li
- Clin Mol Hepatol. 2025;31(1):147-165. Published online October 2, 2024
-
View: 1937 Download: 486
- Self-testing strategy to eliminate hepatitis C as per World Health Organization’s goal: Analysis of disease burden and cost-effectiveness
- Gyeongseon Shin, Beom Kyung Kim, SeungJin Bae, Hankil Lee, Sang Hoon Ahn
- Clin Mol Hepatol. 2025;31(1):166-178. Published online October 4, 2024
-
View: 770 Download: 91
- Metabolic dysfunction-associated steatotic liver disease exhibits sex-specific microbial heterogeneity within intestinal compartments
- Carlos Jose Pirola, Maria Silvina Landa, Mariano Schuman, Silvia Inés García, Adrian Salatino, Silvia Sookoian
- Clin Mol Hepatol. 2025;31(1):179-195. Published online October 11, 2024
-
View: 898 Download: 118
- Aberrant fragmentomic features of circulating cell-free mitochondrial DNA enable early detection and prognosis prediction of hepatocellular carcinoma
- Yang Liu, Fan Peng, Siyuan Wang, Huanmin Jiao, Kaixiang Zhou, Wenjie Guo, Shanshan Guo, Miao Dang, Huanqin Zhang, Weizheng Zhou, Xu Guo, Jinliang Xing
- Clin Mol Hepatol. 2025;31(1):196-212. Published online October 15, 2024
-
View: 835 Download: 136 Crossref: 1
- Antiviral therapy for chronic hepatitis B with mildly elevated aminotransferase: A rollover study from the TORCH-B trial
- Yao-Chun Hsu, Chi-Yi Chen, Cheng-Hao Tseng, Chieh-Chang Chen, Teng-Yu Lee, Ming-Jong Bair, Jyh-Jou Chen, Yen-Tsung Huang, I-Wei Chang, Chi-Yang Chang, Chun-Ying Wu, Ming-Shiang Wu, Lein-Ray Mo, Jaw-Town Lin
- Clin Mol Hepatol. 2025;31(1):213-226. Published online October 17, 2024
-
View: 727 Download: 102
- Bariatric surgery reduces long-term mortality in patients with metabolic dysfunction-associated steatotic liver disease and cirrhosis
- Nicholas A. Rouillard, Scott D. Barnett, Xinrong Zhang, Leslie Kam, Richie Manikat, Ramsey Cheung, Mindie H. Nguyen
- Clin Mol Hepatol. 2025;31(1):227-239. Published online November 14, 2024
-
View: 853 Download: 80
- Insertion of a transjugular intrahepatic portosystemic shunt leads to sustained reversal of systemic inflammation in patients with decompensated liver cirrhosis
- Anja Tiede, Lena Stockhoff, Zhaoli Liu, Hannah Rieland, Jim B. Mauz, Valerie Ohlendorf, Birgit Bremer, Jennifer Witt, Anke Kraft, Markus Cornberg, Jan B. Hinrichs, Bernhard C. Meyer, Heiner Wedemeyer, Cheng-Jian Xu, Christine S. Falk, Benjamin Maasoumy
- Clin Mol Hepatol. 2025;31(1):240-255. Published online November 21, 2024
-
View: 712 Download: 124 Crossref: 1
- Editorial
- Spotting undiagnosed significant liver fibrosis in the general population: impact on subsequent clinical care: Editorial on “Prevalence of clinically significant liver fibrosis in the general population: A systematic review and meta-analysis”
- Nana Peng, Mary Yue Wang, Sherlot Juan Song, Terry Cheuk-Fung Yip
- Clin Mol Hepatol. 2025;31(1):256-260. Published online September 3, 2024
-
View: 445 Download: 32
- Hepatocellular carcinoma surveillance after sustained virological response in chronic hepatitis C: Editorial on “Non-invasive prediction of post-sustained virological response hepatocellular carcinoma in hepatitis C virus: A systematic review and meta-analysis”
- Ho Soo Chun, Minjong Lee
- Clin Mol Hepatol. 2025;31(1):261-263. Published online September 20, 2024
-
View: 440 Download: 24
- Towards unification of liver stiffness measurement cutoffs: Editorial on “Optimal cut-offs of vibration-controlled transient elastography and magnetic resonance elastography in diagnosing advanced liver fibrosis in patients with nonalcoholic fatty liver disease: A systematic review and meta-analysis”
- Yangyue Zhang, Vincent Wai-Sun Wong
- Clin Mol Hepatol. 2025;31(1):264-267. Published online September 20, 2024
-
View: 466 Download: 20 Crossref: 1
- The use of transient elastography for predicting hepatocellular carcinoma in chronic hepatitis B patients: Editorial on “Risk assessment of hepatitis B virus-related hepatocellular carcinoma development using vibration-controlled transient elastography: Systematic review and meta-analysis”
- Mirko Zoncapè, Emmanuel A. Tsochatzis
- Clin Mol Hepatol. 2025;31(1):268-274. Published online September 24, 2024
-
View: 557 Download: 34
- Transient elastography for assessing liver fibrosis in autoimmune liver diseases: Excellent performance but limited details: Editorial on “Diagnostic accuracy of vibration-controlled transient elastography for staging liver fibrosis in autoimmune liver diseases: A systematic review and meta-analysis”
- Kyung-Ah Kim
- Clin Mol Hepatol. 2025;31(1):275-276. Published online October 8, 2024
-
View: 459 Download: 24
- Essential tools for assessing advanced fibrosis in metabolic dysfunction-associated steatotic liver disease: Editorial on “Optimal cut-offs of vibration-controlled transient elastography and magnetic resonance elastography in diagnosing advanced liver fibrosis in patients with nonalcoholic fatty liver disease: A systematic review and meta-analysis”
- Won Sohn
- Clin Mol Hepatol. 2025;31(1):277-280. Published online October 11, 2024
-
View: 559 Download: 23
- UBE2S: A novel driver of HIF-1alpha-induced metabolic reprogramming in hepatocellular carcinoma: Editorial on “UBE2S promotes glycolysis in hepatocellular carcinoma by enhancing E3 enzyme-independent polyubiquitination of VHL”
- Martina Mang Leng Lei, Terence Kin Wah Lee
- Clin Mol Hepatol. 2025;31(1):281-285. Published online July 23, 2024
-
View: 945 Download: 67
- From past to pandemic: Health disparities in US hepatobiliary cancer mortality before and during COVID-19: Editorial on “Burden of mortality from hepatocellular carcinoma and biliary tract cancers by race and ethnicity and sex in US, 2018–2023”
- Ilona Argirion
- Clin Mol Hepatol. 2025;31(1):286-289. Published online August 5, 2024
-
View: 452 Download: 23
- MASLD after hepatitis C virus eradication: Do not overlook the cardiometabolic risk factors: Editorial on “Dynamic change of metabolic dysfunction-associated steatotic liver disease in chronic hepatitis C patients after viral eradication: A nationwide registry study in Taiwan”
- Rex Wan-Hin Hui, Lung-Yi Mak
- Clin Mol Hepatol. 2025;31(1):290-292. Published online August 7, 2024
-
View: 427 Download: 15
- TM6SF2 and PNPLA3: A potential dynamic duo?: Editorial on “TM6SF2 E167K variant decreases PNPLA3-mediated PUFA transfer to promote hepatic steatosis and injury in MASLD”
- Andrea Caddeo, Rosellina M. Mancina
- Clin Mol Hepatol. 2025;31(1):293-296. Published online August 27, 2024
-
View: 704 Download: 92
- A complement to epigenetics in metabolic dysfunction-associated steatotic liver disease: Editorial on “DNA methylome analysis reveals epigenetic alteration of complement genes in advanced metabolic dysfunction-associated steatotic liver disease”
- Johanna K. DiStefano, Glenn S. Gerhard
- Clin Mol Hepatol. 2025;31(1):297-300. Published online August 27, 2024
-
View: 520 Download: 23
- Unveiling the distinctive gut microbiota and metabolites in liver cirrhosis and its complications: Novel diagnostic biomarkers: Editorial on “Gut microbiome and metabolome signatures in liver cirrhosis-related complications”
- Soon Kyu Lee, Jong Young Choi
- Clin Mol Hepatol. 2025;31(1):301-303. Published online August 30, 2024
-
View: 572 Download: 59 Crossref: 1
- Identification of KCTD17 as a Ras stabilizer in hepatocellular carcinoma: Editorial on “KCTD17-mediated Ras stabilization promotes hepatocellular carcinoma progression”
- Rainbow Wing Hei Leung, Terence Kin Wah Lee
- Clin Mol Hepatol. 2025;31(1):304-307. Published online August 30, 2024
-
View: 568 Download: 34 Crossref: 1
- Transcriptomic signature in advanced hepatocellular carcinoma tissue to predict combination immunotherapy response: Editorial on “Genomic biomarkers to predict response to atezolizumab plus bevacizumab immunotherapy in hepatocellular carcinoma: Insights from the IMbrave150 trial”
- Hiroaki Kanzaki, Yujin Hoshida
- Clin Mol Hepatol. 2025;31(1):308-310. Published online August 30, 2024
-
View: 547 Download: 51 Crossref: 1
- Personalized approaches to the treatment of hepatocellular carcinoma using immune checkpoint inhibitors: Editorial on “Genomic biomarkers to predict response to atezolizumab plus bevacizumab immunotherapy in hepatocellular carcinoma: Insights from the IMbrave150 trial”
- Naoshi Nishida
- Clin Mol Hepatol. 2025;31(1):311-315. Published online September 3, 2024
-
View: 500 Download: 43 Crossref: 1
- The urgent need for multidisciplinary approaches in managing alcohol-associated liver disease: Editorial on “The prognostic impact of psychiatric intervention on alcohol-associated liver disease: The UK Biobank cohort study”
- Soon Sun Kim, Jae Youn Cheong
- Clin Mol Hepatol. 2025;31(1):316-318. Published online October 7, 2024
-
View: 415 Download: 37
- Understanding the impact on digestive disease in the post-COVID-19 condition: Editorial on “Long-term gastrointestinal and hepatobiliary outcomes of COVID-19: A multinational population-based cohort study from South Korea, Japan, and the UK”
- Yang-Hyun Baek
- Clin Mol Hepatol. 2025;31(1):319-322. Published online October 7, 2024
-
View: 411 Download: 22
- Stroma-tology: Predicting recurrence in cholangiocarcinoma: Editorial on “Development and validation of a stromal-immune signature to predict prognosis in intrahepatic cholangiocarcinoma”
- Sergi Marco, Chiara Braconi
- Clin Mol Hepatol. 2025;31(1):323-326. Published online October 29, 2024
-
View: 369 Download: 28 Crossref: 1
- Snapshot
- Metabolic dysfunction-associated steatotic liver disease across women’s reproductive lifespan and issues
- Clara Meda, Arianna Dolce, Sara Della Torre
- Clin Mol Hepatol. 2025;31(1):327-332. Published online August 5, 2024
-
View: 537 Download: 58
- Letter to the Editor
- Accountability in AI medicine: A critical appraisal of ChatGPT in patient self-management and screening
- Jiawen Wang, Tian Xia
- Clin Mol Hepatol. 2025;31(1):e1-e2. Published online September 26, 2024
-
View: 470 Download: 38
- Comparison of the therapeutic effects of transarterial radioembolization and tyrosine kinase inhibitor in hepatocellular carcinoma with portal vein thrombosis
- Hang Li, Hua Lu, Xi-Ping Shen, Xiao-Song Li
- Clin Mol Hepatol. 2025;31(1):e3-e4. Published online October 7, 2024
-
View: 511 Download: 40 Crossref: 1
- Contemporary awareness of viral hepatitis between 2012 and 2022 among Korean adults
- Donghee Kim, Won Kim, Aijaz Ahmed
- Clin Mol Hepatol. 2025;31(1):e5-e7. Published online October 8, 2024
-
View: 445 Download: 27
- Insights on risk score development: Considerations for early-stage hepatocellular carcinoma models
- Zhanna Zhang, Gongqiang Wu
- Clin Mol Hepatol. 2025;31(1):e8-e9. Published online November 6, 2024
-
View: 393 Download: 21
- Grading severity of microvascular invasion in hepatocellular carcinoma: More details, more significance
- Xiu-Ping Zhang, Fei-Fan Wu, Tian-Chen Zhang, Zhen-Qi Li, Ming-Gen Hu, Rong Liu
- Clin Mol Hepatol. 2025;31(1):e10-e12. Published online November 26, 2024
-
View: 425 Download: 47
- Letter to the editor on “Sorafenib vs. Lenvatinib in advanced hepatocellular carcinoma after atezolizumab/bevacizumab failure: A real-world study”
- Meng-Che Wu, Hui-Chin Chang, Yi-Sheng Jhang, Shuo-Yan Gau
- Clin Mol Hepatol. 2025;31(1):e13-e14. Published online September 2, 2024
-
View: 768 Download: 78
- Letter to the editor on “Bariatric intervention improves metabolic dysfunction-associated steatohepatitis in patients with obesity: A systematic review and meta-analysis”
- Xiao-Song Li, Xi-Ping Shen, Hang Li
- Clin Mol Hepatol. 2025;31(1):e15-e16. Published online September 12, 2024
-
View: 505 Download: 29 Crossref: 1
- Development of risk scores for prognosis prediction among patients with early-stage hepatocellular carcinoma
- Xiping Shen, Ji Wu
- Clin Mol Hepatol. 2025;31(1):e17-e18. Published online October 11, 2024
-
View: 604 Download: 42
- Chronic hepatitis B, extrahepatic malignancies and the use of antiviral drugs
- Meng-Che Wu, Shih-Chi Yang, Shuo-Yan Gau
- Clin Mol Hepatol. 2025;31(1):e19-e20. Published online October 17, 2024
-
View: 403 Download: 24
- Letter regarding “Prevalence of clinically significant liver fibrosis in the general population”
- Wei Feng, Qile Wang, Qingwang Ye
- Clin Mol Hepatol. 2025;31(1):e21-e22. Published online October 11, 2024
-
View: 539 Download: 23
- Comment: Non-invasive prediction of post-sustained virological response hepatocellular carcinoma in hepatitis C virus
- Xinpu Miao, Haidong Wu, Jinrong Xu, Wei Cheng
- Clin Mol Hepatol. 2025;31(1):e23-e24. Published online November 26, 2024
-
View: 316 Download: 14
- The fibrosis-4 index for advanced liver fibrosis in NAFLD with T2DM: Half a loaf is better than no bread
- Zeyu Wang, Dong Wan, Meidong Xu, Yong Jiang
- Clin Mol Hepatol. 2025;31(1):e25-e26. Published online December 10, 2024
-
View: 394 Download: 34
- Presence of liver fibrosis in chronic hepatitis B patients with varying serum hepatitis B virus DNA levels: Letter to the editor on “Non-linear association between liver fibrosis scores and viral load in patients with chronic hepatitis B”
- Jian Wang, Shaoqiu Zhang, Chuanwu Zhu, Yuanwang Qiu, Chao Wu, Rui Huang
- Clin Mol Hepatol. 2025;31(1):e27-e30. Published online August 7, 2024
-
View: 486 Download: 30 Crossref: 1
- Comprehensive analysis of transcriptomic biomarkers for predicting response to atezolizumab plus bevacizumab immunotherapy in hepatocellular carcinoma
- Binghua Li, Jingyuan Wen, Zhu Xu, Peng Yan, Bing Han, Decai Yu
- Clin Mol Hepatol. 2025;31(1):e31-e34. Published online September 20, 2024
-
View: 654 Download: 86 Crossref: 1
- Sex-specific associations of metabolic dysfunction-associated steatotic liver disease with cardiovascular outcomes
- Meng-Yuan Miao, Jie-Qiong Lyu, Wei Jiang, Zhong-Yue Liu, Guo-Chong Chen
- Clin Mol Hepatol. 2025;31(1):e35-e38. Published online September 20, 2024
-
View: 579 Download: 54
- Urgent need for education on hepatocellular carcinoma surveillance among high-risk population in China
- Lei Cai, Chao Li, Li-Yang Sun, Yong-Kang Diao, Ming-Da Wang, Tian Yang
- Clin Mol Hepatol. 2025;31(1):e39-e43. Published online October 23, 2024
-
View: 464 Download: 44
- Correspondence
- Correspondence to editorial on “Genetically-modified, redirected T cells target hepatitis B surface antigen-positive hepatocytes and hepatocellular carcinoma lesions in a clinical setting”
- Shunda Du, Karin Wisskirchen, Ke Zhang, Ulrike Protzer
- Clin Mol Hepatol. 2025;31(1):e44-e47. Published online October 21, 2024
-
View: 607 Download: 36
- Correspondence to editorial on “Prevalence of clinically significant liver fibrosis in the general population: A systematic review and meta-analysis”
- Hee Yeon Kim, Miyoung Choi, Dae Won Jun
- Clin Mol Hepatol. 2025;31(1):e48-e51. Published online September 11, 2024
-
View: 441 Download: 20
- Correspondence to editorial on “Optimal cutoffs of vibration-controlled transient elastography and magnetic resonance elastography in diagnosing advanced liver fibrosis in patients with nonalcoholic fatty liver disease: A systematic review and meta-analysis”
- Jung Hwan Yu, Seung Up Kim
- Clin Mol Hepatol. 2025;31(1):e52-e54. Published online September 24, 2024
-
View: 507 Download: 24
- Correspondence to editorial on “Risk assessment of hepatitis B virus-related hepatocellular carcinoma development using vibration-controlled transient elastography: Systematic review and meta-analysis”
- Young-Joo Jin, Seung Up Kim
- Clin Mol Hepatol. 2025;31(1):e55-e57. Published online October 7, 2024
-
View: 430 Download: 15 Crossref: 1
- Correspondence to editorial on “UBE2S promotes glycolysis in hepatocellular carcinoma by enhancing E3 enzyme-independent polyubiquitination of VHL”
- Renyu Zhang, Ding Wei, Zhinan Chen, Huijie Bian
- Clin Mol Hepatol. 2025;31(1):e58-e60. Published online July 29, 2024
-
View: 578 Download: 48
- Correspondence to editorial on “Optimal cut-offs of vibration-controlled transient elastography and magnetic resonance elastography in diagnosing advanced liver fibrosis in patients with nonalcoholic fatty liver disease: a systematic review and meta-analysis”
- Young Eun Chon, Jung Hwan Yu, Seung Up Kim
- Clin Mol Hepatol. 2025;31(1):e61-e63. Published online October 15, 2024
-
View: 436 Download: 18
- Steatotic liver disease in chronic hepatitis C related hepatocellular carcinoma: Inflictor or bystander?: Correspondence to editorial on “Dynamic change of metabolic dysfunction-associated steatotic liver disease in chronic hepatitis C patients after viral eradication: A nationwide registry study in Taiwan”
- Chung-Feng Huang, Ming-Lun Yeh, Chia-Yen Dai, Jee-Fu Huang, Wan-Long Chuang, Ming-Lung Yu
- Clin Mol Hepatol. 2025;31(1):e64-e66. Published online August 19, 2024
-
View: 530 Download: 33 Crossref: 1
- PNPLA3 is one of the bridges between TM6SF2 E167K variant and MASLD: Correspondence to editorial on “TM6SF2 E167K variant decreases PNPLA3-mediated PUFA transfer to promote hepatic steatosis and injury in MASLD”
- Baokai Sun, Likun Zhuang
- Clin Mol Hepatol. 2025;31(1):e67-e69. Published online September 10, 2024
-
View: 542 Download: 67
- Correspondence to editorial on “DNA methylome analysis reveals epigenetic alteration of complement genes in advanced metabolic dysfunction-associated steatotic liver disease”
- Amal Magdy, Hee-Jin Kim, Won Kim, Mirang Kim
- Clin Mol Hepatol. 2025;31(1):e70-e73. Published online September 10, 2024
-
View: 504 Download: 39
- Correspondence to editorial on: “Gut microbiome and metabolome signatures in liver cirrhosis-related complications”
- Satya Priya Sharma, Ki Tae Suk
- Clin Mol Hepatol. 2025;31(1):e74-e77. Published online October 15, 2024
-
View: 684 Download: 38
- Correspondence to editorial on “KCTD17-mediated Ras stabilization promotes hepatocellular carcinoma progression”
- Sang Bae Lee, KyeongJin Kim
- Clin Mol Hepatol. 2025;31(1):e78-e80. Published online September 10, 2024
-
View: 559 Download: 56
- Correspondence to editorial 1 on “Genomic biomarkers to predict response to atezolizumab plus bevacizumab immunotherapy in hepatocellular carcinoma: insights from the IMbrave150 Trial”
- Sung Hwan Lee, Sun Young Yim, Ji Hoon Kim, Sunyoung S. Lee, Ahmed O. Kaseb, Ju-Seog Lee
- Clin Mol Hepatol. 2025;31(1):e81-e83. Published online October 7, 2024
-
View: 510 Download: 25
- Correspondence to editorial 2 on “Genomic biomarkers to predict response to atezolizumab plus bevacizumab immunotherapy in hepatocellular carcinoma: insights from the IMbrave150 trial”
- Sun Young Yim, Sung Hwan Lee, Ji Hoon Kim, Sunyoung S Lee, Ahmed O Kaseb, Ju-Seog Lee
- Clin Mol Hepatol. 2025;31(1):e84-e86. Published online October 7, 2024
-
View: 464 Download: 19
- Correspondence to editorial on “Long-term gastrointestinal and hepatobiliary outcomes of COVID-19: a multinational population-based cohort study from South Korea, Japan, and the UK”
- Kwanjoo Lee, Jaeyu Park, Jinseok Lee, Hayeon Lee, Yeonjung Ha, Dong Keon Yon
- Clin Mol Hepatol. 2025;31(1):e87-e89. Published online October 29, 2024
-
View: 373 Download: 11 Crossref: 1
- Correspondence to editorial on “Development and validation of a stromal-immune signature to predict prognosis in intrahepatic cholangiocarcinoma”
- Yu-Hang Ye, Shao-Lai Zhou
- Clin Mol Hepatol. 2025;31(1):e90-e92. Published online November 11, 2024
-
View: 381 Download: 13
- Correspondence to letter to the editor on “Transarterial radioembolization versus tyrosine kinase inhibitor in hepatocellular carcinoma with portal vein thrombosis”
- Moon Haeng Hur, Yoon Jun Kim
- Clin Mol Hepatol. 2025;31(1):e93-e95. Published online November 6, 2024
-
View: 446 Download: 26
- Correspondence to letter to the editor 1 on “Conventional and machine learning-based risk scores for patients with early-stage hepatocellular carcinoma”
- Chun-Ting Ho, Elise Chia-Hui Tan, Chien-Wei Su
- Clin Mol Hepatol. 2025;31(1):e96-e97. Published online November 11, 2024
-
View: 328 Download: 9
- Correspondence to letter to the editor on “Sorafenib vs. lenvatinib in advanced hepatocellular carcinoma after atezolizumab/bevacizumab failure: a real-world study”
- Young Eun Chon, Dong Yun Kim, Hong Jae Chon, Do Young Kim
- Clin Mol Hepatol. 2025;31(1):e98-e100. Published online October 21, 2024
-
View: 466 Download: 32
- Correspondence to letter to the editor 2 on “Conventional and machine learning-based risk scores for patients with early-stage hepatocellular carcinoma”
- Chun-Ting Ho, Elise Chia-Hui Tan, Chien-Wei Su
- Clin Mol Hepatol. 2025;31(1):e101-e102. Published online November 6, 2024
-
View: 334 Download: 11
- Correspondence to letter to the editor on “Bariatric intervention improves metabolic dysfunction-associated steatohepatitis in patients with obesity: A systematic review and meta-analysis”
- Yuri Cho, Dae Won Jun
- Clin Mol Hepatol. 2025;31(1):e103-e104. Published online September 24, 2024
-
View: 446 Download: 25
- Correspondence to letter to the editor on “Prevalence of clinically significant liver fibrosis in the general population: A systematic review and meta-analysis”
- Hee Yeon Kim, Miyoung Choi, Dae Won Jun
- Clin Mol Hepatol. 2025;31(1):e105-e107. Published online November 4, 2024
-
View: 330 Download: 17
- Correspondence to letter to the editor on “Non-linear association between liver fibrosis scores and viral load in patients with chronic hepatitis B”
- Gi-Ae Kim, Seung Won Choi, Young-Suk Lim
- Clin Mol Hepatol. 2025;31(1):e108-e109. Published online August 5, 2024
-
View: 486 Download: 27
- Correspondence to letter to the editor on “Genomic biomarkers to predict response to atezolizumab plus bevacizumab immunotherapy in hepatocellular carcinoma: Insights from the IMbrave150 trial”
- Sung Hwan Lee, Sun Young Yim, Ji Hoon Kim, Sunyoung S Lee, Ahmed O Kaseb, Peng Wei, Ju-Seog Lee
- Clin Mol Hepatol. 2025;31(1):e110-e112. Published online October 2, 2024
-
View: 535 Download: 37
- Reply to Correspondence
- Reply to correspondence on “Genetically-modified, redirected T cells target hepatitis B surface antigen-positive hepatocytes and hepatocellular carcinoma lesions in a clinical setting”
- Antonio Bertoletti, Anthony T Tan
- Clin Mol Hepatol. 2025;31(1):e113-e116. Published online October 11, 2024
-
View: 576 Download: 24
- Reply to correspondence on “Risk assessment of hepatitis B virus-related hepatocellular carcinoma development using vibration-controlled transient elastography: Systematic review and meta-analysis”
- Mirko Zoncapè, Emmanuel A. Tsochatzis
- Clin Mol Hepatol. 2025;31(1):e117-e118. Published online November 11, 2024
-
View: 330 Download: 13
- Reply to correspondence on “UBE2S: A novel driver of HIF-1alpha-induced metabolic reprogramming in hepatocellular carcinoma”
- Martina Mang Leng Lei, Terence Kin Wah Lee
- Clin Mol Hepatol. 2025;31(1):e119-e120. Published online August 5, 2024
-
View: 505 Download: 26
- Reply to correspondence on “Genomic biomarkers to predict response to atezolizumab plus bevacizumab immunotherapy in hepatocellular carcinoma: Insights from the IMbrave150 trial”
- Hiroaki Kanzaki, Yujin Hoshida
- Clin Mol Hepatol. 2025;31(1):e121-e122. Published online October 11, 2024
-
View: 495 Download: 22
- Reply to correspondence on “Long-term gastrointestinal and hepatobiliary outcomes of COVID-19: A multinational population-based cohort study from South Korea, Japan, and the UK”
- Yang-Hyun Baek
- Clin Mol Hepatol. 2025;31(1):e123-e124. Published online November 6, 2024
-
View: 310 Download: 10
